eFFECTOR Therapeutics, Inc.
EFTRDelisted Jul 19, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828522
eFFECTOR Therapeutics, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $251.1K in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding eFFECTOR Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 24 | 17 | −7 |
| SharesConverted for a 1-for-25 split | 467.5K | 938.8K | +471.4K (+100.8%) |
| Value | $5.44M | $13.5M | +$8.02M (+147.5%) |
New holders (6)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 223,000 | $3.21M | 0.09% |
| StemPoint Capital LP | 132,793 | $1.91M | 0.51% |
| Ensign Peak Advisors, Inc | 32,945 | $474.1K | 0.00% |
| Raymond James & Associates | 12,345 | $177.6K | 0.00% |
| Sea Otter Advisors LLC | 10,557 | $151.9K | 0.79% |
| ICA Group Wealth Management, LLC | 247 | $3.56K | 0.00% |
Sold out (13)
Institutions that held eFFECTOR Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Northern Trust Corp | 160,812 | $75.2K |
| Sonora Investment Management Group, LLC | 125,000 | $58.4K |
| Two Sigma Securities, LLC | 61,694 | $28.8K |
| State Street Corp | 30,885 | $14.4K |
| Wescott Financial Advisory Group, LLC | 30,556 | $14.3K |
| Stifel Financial Corp | 22,660 | $10.6K |
| Callan Capital, LLC | 20,000 | $9.35K |
| Vontobel Holding Ltd. | 15,000 | $7.01K |
| UBS Group AG | 9,092 | $4.25K |
| BlackRock Inc. | 554 | $259 |
| JPMorgan Chase & Co | 68 | $32 |
| Bank of America Corp | 27 | $13 |
| Simplex Trading, LLC | 1,735 | $0 |